Martin Schäfer

Apr 12, 2023 | ard.bmj.com | Pedro Machado |Martin Schäfer |Anja Strangfeld |Laure Gossec

http://orcid.org/0000-0002-8411-7972Pedro M Machado1,2,3, Martin Schäfer4, http://orcid.org/0000-0002-6233-022XAnja Strangfeld4, http://orcid.org/0000-0002-4528-310XLaure Gossec5,6, Milena Gianfrancesco7, Saskia Lawson-Tovey8,9, Elsa F Mateus10,11, http://orcid.org/0000-0002-4401-2551Loreto Carmona12, http://orcid.org/0000-0001-8242-9262Kimme L Hyrich8,9, http://orcid.org/0000-0002-3156-3418Philip C Robinson13,14, Jinoos Yazdany7 1 Centre for Rheumatology and Department of Neuromuscular...

Feb 14, 2023 | ard.bmj.com | Pedro Machado |Martin Schäfer |Satveer K. Mahil |Jean W. Liew

DiscussionIn this registry-based study of individuals with PsO, PsA and axSpA with SARS-CoV-2 infection, we found that known risk factors for the general population (older age, the presence of comorbidities) and for IMIDs overall (higher disease activity, higher baseline GC usage) were associated with more severe COVID-19 outcomes. In addition, a diagnosis of COVID-19 in a later time period during the pandemic was associated with lower disease severity compared with early 2020.